Researchers are beginning a highly anticipated study of two possible treatments for the Ebola outbreak in eastern Congo

The Bundibugyo strain has no approved vaccine or targeted treatment, leaving supportive care as the primary option.

More than 1,400 people have been diagnosed and 438 have died

Estudo avalia anticorpo monoclonal MBP134 e antiviral remdesivir, separadamente e combinados

Researchers are beginning a highly anticipated study of two possible treatments for the Ebola outbreak in eastern Congo

Cette étude est coordonnée par l'Institut national de recherche biomédicale de la République démocratique du Congo, avec le soutien d'une coalition de partenaires dont l'OMS.

There are currently no approved treatments for Ebola's Bundibugyo strain, which has caused 438 deaths in DRC

The trial of two potential treatments for the Bundibugyo species of Ebola behind the deadly outbreak in the DR Congo began in the country on Thursday, the World Health…

A first ray of hope for Ebola patients in the Democratic Republic of the Congo as the trial of two potential treatments for the virus gets underway.

A clinical trial for Ebola treatments targeting the current outbreak in the Democratic Republic of Congo has commenced, enrolling its first patient, WHO announced.

An international clinical trial has begun enrolling patients in the Democratic Republic of the Congo (DRC) in a step towards identifying the first effective treatment for…

The Democratic Republic of Congo has launched a clinical trial of experimental Ebola treatments as the outbreak continues to spread in the north-east of the country.

Eine seltene Variante des Ebola-Virus verbreitet sich schnell in Ostkongo. Jetzt werden zwei antivirale Therapien in den besonders betroffenen Regionen an Menschen getestet.